|
ABT
|
Abbott Laboratories
|
US
|
NYSE
|
|
AMPE
|
Ampio Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
BDXB
|
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
|
US
|
NYSE
|
|
BMRA
|
Biomerica, Inc.
|
US
|
NASDAQ
|
|
COO
|
Cooper Companies, Inc. (The)
|
US
|
NYSE
|
|
HSKA
|
Heska Corporation
|
US
|
NASDAQ
|
|
IDXX
|
IDEXX Laboratories, Inc.
|
US
|
NASDAQ
|
|
JNJ
|
Johnson & Johnson
|
US
|
NYSE
|
|
NEOG
|
Neogen Corporation
|
US
|
NASDAQ
|
|
NYMX
|
Nymox Pharmaceutical Corporation
|
US
|
NASDAQ
|
|
OSUR
|
OraSure Technologies, Inc.
|
US
|
NASDAQ
|
|
RMD
|
ResMed Inc.
|
US
|
NYSE
|
|
SNA
|
Snap-On Incorporated
|
US
|
NYSE
|
|
TECH
|
Techne Corporation
|
US
|
NASDAQ
|
|
TRIB
|
Trinity Biotech plc
|
US
|
NASDAQ
|
|
TTOO
|
T2 Biosystems, Inc.
|
US
|
NASDAQ
|
|
VIVO
|
Meridian Bioscience Inc.
|
US
|
NASDAQ
|
|
VNRX
|
VolitionRX Limited
|
US
|
AMEX
|
|
CSL
|
CSL Limited
|
AU
|
ASX
|
|
IIQ
|
INOVIQ Ltd
|
AU
|
ASX
|